Predictors of recovery of ovarian function during aromatase inhibitor therapy
نویسندگان
چکیده
منابع مشابه
Predictors of recovery of ovarian function during aromatase inhibitor therapy.
BACKGROUND Aromatase inhibitors (AIs) may cause a rise in estrogen levels due to ovarian function recovery in women with clinical chemotherapy-induced ovarian failure (CIOF). We carried out a prospective registry trial to identify predictors of ovarian function recovery during AI therapy. PATIENTS AND METHODS Women with hormone receptor (HR)-positive breast cancer who remained amenorrheic and...
متن کاملAppraising adjuvant aromatase inhibitor therapy.
Tamoxifen, once the gold standard adjuvant endocrine therapy for early breast cancer, is being challenged by third-generation aromatase inhibitors (AIs) that have demonstrated improved disease-free survival in a variety of adjuvant settings for early breast cancer. Tamoxifen and AIs have different safety profiles, which should allow physicians to begin to individualize treatment based on a pati...
متن کاملinterpersonal function of language in subtitling
translation as a comunicative process is always said to be associated with various aspects of meaning loss or gain. subtitling as a mode of translating, due to special discoursal and textual conditions imposed upon it, is believed to be an obvious case of this loss or gain. presenting the spoken sound track of a film in writing and synchronizing the perception of this text by the viewers with...
15 صفحه اولEffects of a non-steroidal aromatase inhibitor on ovarian function in cattle.
Effects of the non-steroidal aromatase inhibitor letrozole on ovarian function in cattle were determined. The hypothesis that letrozole would arrest growth of the dominant follicle, resulting in emergence of a new follicular wave at a predictable post-treatment interval, was tested. Heifers were assigned randomly to four groups 4 days after follicular ablation (~2½ days after wave emergence) an...
متن کاملEruptive keloids associated with aromatase inhibitor therapy
INTRODUCTION Eruptive keloids are rarely described in the literature and are typically reported in association with a systemic disease. Because reports of eruptive keloids are sparse, the pathophysiology of eruptive keloids remains to be clearly explained. We report a case of a 77-year-old woman who had extensive eruptive keloids while taking letrozole for hormone receptorepositive infiltrating...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2013
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt149